Related Experiment Video
Updated: Sep 9, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Clinical Characteristics and Outcomes of Adults with Budd-Chiari Syndrome: A Single-Center Experience in Colombia
Ximena Morales-Cruz1, Carolina Salinas2, Geovanny Hernández-Cely2
1School of Medicine and Health Sciences, Hepatology Program, Universidad del Rosario, Bogota, Colombia, ximena.morales@urosario.edu.co.
Insights
Budd-Chiari syndrome in Colombia is linked to acquired thrombophilias, primarily antiphospholipid syndrome. This study highlights clinical features and mortality rates consistent with global findings for this rare liver disease.
Area of Science:
- Hepatology
- Vascular Medicine
- Internal Medicine
Background:
- Budd-Chiari syndrome involves hepatic venous outflow obstruction.
- Limited data exists on Budd-Chiari syndrome in Colombia.
- This study characterizes patients in a Colombian referral center.
Purpose of the Study:
- To describe clinical characteristics of Budd-Chiari syndrome patients in Colombia.
- To outline management strategies and survival rates.
- To provide insights into this understudied population.
Main Methods:
- Retrospective longitudinal study of 31 adult patients (2010-2022).
- Data collected on demographics, risk factors, clinical presentation, and management.
- Survival analysis was performed.
Main Results:
- Acquired thrombophilias (58.1%) were the primary risk factor, mainly antiphospholipid syndrome.
- Ascites (87.1%) was the most common presentation.
- Mortality rate was 35.5%, with a median survival of 337.1 days.
Conclusions:
- Budd-Chiari syndrome in Colombia is associated with acquired thrombophilias.
- Clinical features and mortality align with international reports.
- Further characterization of this disease in the region is warranted.
Introduction:
Budd-Chiari syndrome is defined as the obstruction of hepatic venous flow. Limited evidence exists in Colombia regarding the characterization of these patients. This study aimed to describe the clinical characteristics, management, and survival of patients diagnosed with Budd-Chiari syndrome in a Colombian hepatology referral center from 2010 to 2022.
Methods:
This is a descriptive retrospective longitudinal study of a cohort of patients with Budd-Chiari syndrome in adult patients diagnosed with Budd-Chiari syndrome in a Colombian hepatology center from January 2010 to January 2022.
Results:
31 patients diagnosed with Budd-Chiari syndrome were included. Of the patients, 61.3% (n = 19) were female. The median age was 28 years [interquartile range (IQR) 23-38]. Acquired thrombophilias were the main risk factor (58.1%, n = 18), mainly secondary to antiphospholipid syndrome (55.5%, n = 10). The primary clinical manifestation presented was ascites 87.1% (n = 27). At diagnosis, 74.2% (n = 23) were in a chronic course, and 5 patients had cirrhosis documented by biopsy. The Rotterdam score was class II (intermediate prognosis) in 48.3% (n = 14). Of the patients, 86% (n = 25) had anticoagulation therapy. Five patients (16.1%) underwent transjugular intrahepatic portosystemic shunt. Eleven patients died (35.5%), with a median survival time from diagnosis to death of 337.1 days (IQR 46.5-647.5).
Conclusion:
Budd-Chiari syndrome is a poorly characterized disease in the Colombian population. This study shows that acquired thrombophilias are the leading risk factor associated with this medical condition in this population, with clinical features and mortality rates similar to those reported in the literature.
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Esophageal Varices-I: Introduction
Chronic Pancreatitis II: Collaborative Care
Assessment:

